logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Ping Fan

This inventor holds 8 USPTO granted patents. Top assignee: Human Genome Sciences, Inc.. Active years: 1999-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ping Fan. Retrieved from https://idiyas.com/inventor/ping-fan-ufj23low

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 87.5

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 79(Granted Patents)


Location History:

  • Gaithersburg, MD (US) (1999 - 2005)
  • Potomac, MD (US) (2005)
  • Rockville, MD (US) (2010)

Company Filing History:

goldMedal8 out of 676 
 
Human Genome Sciences, Inc.
 patents

Years Active: 1999-2010

Loading Chart...
8 patents (USPTO):Explore Patents
1. 7776560 - Human tumor necrosis factor receptor TR9 antibody (2010-08-17),
2. 6949358 - Human tumor necrosis factor receptor TR9 (2005-09-27),
3. 6919078 - Antibodies to human tumor necrosis factor receptor TR9 (2005-07-19),
4. 6667390 - Human tumor necrosis factor receptor TR9 (2003-12-23),
5. 6525174 - Precerebellin-like protein (2003-02-25),
6. 6410709 - Cornichon-like protein (2002-06-25),
7. 6358508 - Antibodies to human tumor necrosis factor receptor TR9 (2002-03-19),
8. 5968780 - Dendritic cell-derived growth factor (1999-10-19),

Title: The Innovations of Ping Fan

Introduction

Ping Fan is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the area of tumor necrosis factor receptors. With a total of 8 patents to his name, his work has had a profound impact on medical research and therapeutic development.

Latest Patents

Among his latest patents is the invention related to the Human tumor necrosis factor receptor TR9 antibody. This invention pertains to a novel member of the tumor necrosis factor family of receptors. Specifically, isolated nucleic acid molecules are provided that encode the human TR9 receptor. Additionally, TR9 polypeptides are included, along with vectors, host cells, and recombinant methods for producing these components. The invention also encompasses screening methods for identifying agonists and antagonists of TR9 receptor activity.

Career Highlights

Ping Fan is currently associated with Human Genome Sciences, Inc., where he continues to advance his research and innovations. His work has been pivotal in understanding the mechanisms of tumor necrosis factor receptors and their potential therapeutic applications.

Collaborations

Throughout his career, Ping Fan has collaborated with esteemed colleagues such as Jian Ni and Guo-Liang Yu. These collaborations have further enriched his research and contributed to the advancement of their shared field.

Conclusion

Ping Fan's contributions to biotechnology and his innovative patents highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical research and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…